glp 1 podcast Podcast: Boosting GLP-1 with Diet and Lifestyle GLP-1 Meds Explained | Obesity,

What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss

Total Phosphatidylcholine (PC) 500 mg /

Source: Butterfield, D

Made in USA in an FDA Registered Facility using Good Manufacturing Practices (GMPs) *These statements have not been evaluated by the Food and Drug Administration